Jubilant Biosys Limited

Jubilant Biosys Limited - pharma in Noida, Uttar Pradesh, India. FY 2026 financials and compliance.
CIN U24110UP1998PLC029591 Incorporated 10 February 1998 ROC Kanpur HQ Noida, Uttar Pradesh, India
Active Public Limited Company pharma
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
*****
In full report
Net profit · Latest
*****
In full report
Authorised capital
₹328 Cr
Registered with MCA
Paid-up capital
₹303.7 Cr
Issued & subscribed
Open charges
₹615 Cr
Satisfied ₹14.3 Cr
Company age
28 yrs
Est. 1998
Last financials
Mar 2025
Balance sheet date

About Jubilant Biosys Limited

Data last updated: 22 December 2025

Jubilant Biosys Limited is a public limited company based in Noida, Uttar Pradesh, India, a subsidiary of Jubilant Pharmova Limited. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 10 February 1998, the company has been in operation for over 28 years.

Registered with ROC Kanpur under CIN U24110UP1998PTC029591.

Capital: an authorised share capital of ₹328 Cr and a paid-up capital of ₹303.7 Cr. Formerly known as Jubilant Biosys Private Limited. It is led by directors including Arvind Chokhany and Prasant Kumar Deb.

Last AGM: 28 August 2025. Financial statements filed for year ended 31 March 2025. Office: 1A Sector 16 A, Noida, Uttar Pradesh, India – 201301.

It operates as a subsidiary of Jubilant Pharmova Limited.

The company is associated with 1 brand - Jubilant Biosys. As per MCA filings, the company has open charges of ₹615 Cr and satisfied charges of ₹14.3 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jubilantbiosys.com.

Company Details of Jubilant Biosys Limited
CIN U24110UP1998PLC029591
Registration Number 029591
Incorporation Date 10 February 1998
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 28 August 2025
Date of Balance Sheet 31 March 2025
Parent Company Jubilant Pharmova Limited
Compliance Status Active Compliant
Key People
Giuliano Perfetti Managing Director Prasant Kumar Deb Whole-Time Director Arul Ramakrishnan Whole-Time Director
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
  • Registered Address
    1A Sector 16 A, Noida, Uttar Pradesh, India – 201301
  • Industry
    Pharma, Pharma Contract R&D
Company report
Jubilant Biosys Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Jubilant Biosys Limited report

Financials, compliance, directors, charges, ownership and filings for Jubilant Biosys Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Jubilant Biosys Limited

Jubilant Biosys Limited has one previous CIN (Corporate Identification Number): U24110UP1998PTC029591. The current CIN is U24110UP1998PLC029591, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24110UP1998PLC029591 Current
U24110UP1998PTC029591 Previous

Associated Brands with Jubilant Biosys Limited

Jubilant Biosys Limited operates one associated brand: Jubilant Biosys. These brands represent Jubilant Biosys Limited's diversified market presence and brand portfolio.

Brand Description Website
Jubilant Biosys
Offers integrated drug discovery, research, and manufacturing for pharmaceuticals. jubilantbiosys.com

Competitors & Alternatives of Jubilant Biosys Limited

Brands and companies operating in the same space as Jubilant Biosys Limited include Evotec, Crown Bioscience, NIH and 7 more.

Competitor Description Location Founded
Evotec Evotec Drug discovery and development services are provided to biopharma sector. Hamburg, Germany, Germany 1993
Crown Bioscience Crown Bioscience Cancer and CVMD drugs are developed using PDX models. Santa Clara, United States, United States 2006
NIH NIH Drug discovery services are provided to the biopharma sector. United States 1887
Domainex Domainex Drug discovery CRO company for epigenetic research and inflammatory diseases Cambridge, United Kingdom, United Kingdom 2001
Alloy Therapeutics Alloy Therapeutics Drug discovery services are provided for therapeutic development. Lexington, United States, United States 2017
STAQ Pharma STAQ Pharma Drug discovery services are provided for pharmaceutical innovation. Denver, United States, United States 2018
Viva Biotech Viva Biotech Drug discovery and development research services are provided. Shanghai, China, China 2006
Qyuns Therapeutics Qyuns Therapeutics Drug development services are provided to the biopharma sector. Taizhou, China, China 2015
Concept Life Sciences Concept Life Sciences International laboratory testing and consultancy in life sciences are offered. Manchester, United Kingdom, United Kingdom 2014
CatSci CatSci Drug discovery services are provided to pharmaceutical clients worldwide. Cardiff, United Kingdom, United Kingdom 2010

Business Activity of Jubilant Biosys Limited

Jubilant Biosys Limited operates primarily in the professional, scientific and technical sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
********* Professional, Scientific and Technical ********* Scientific research and development *********

Board of Directors of Jubilant Biosys Limited

Jubilant Biosys Limited is currently managed by 9 directors, with 29 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Arvind Chokhany
Also directs: Jubilant Pharmova Limited
Director 03 Jun 2021 5 Years 1 Months Current
Prasant Kumar Deb Whole-Time Director 03 Jun 2021 5 Years 1 Months Current
Gayatri Taragi
Also directs: Jubilant Generics Limited, Jubilant Agro Sciences Limited
Director 29 Apr 2023 3 Years 2 Months Current
Irfan Ali Company Secretary 09 Jan 2018 8 Years 6 Months Current
Giuliano Perfetti Managing Director 27 Jan 2022 4 Years 5 Months Current
Arul Ramakrishnan Whole-Time Director 01 Sep 2025 0 Years 10 Months Current
Showing 6 of 9 current directors. View all directors

Financials of Jubilant Biosys Limited FY 2025 filings available

Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings of Jubilant Biosys Limited

Open charges
₹615 Cr
Satisfied charges
₹14.3 Cr
Breakdown by lending institutions
The Hongkong and Shanghai Banking Corporation Limited₹400.00 Cr
Others₹120.00 Cr
Yes Bank Limited₹50.00 Cr
Hdfc Bank Limited₹45.00 Cr
Latest charge details
DateLenderAmountStatus
11 Nov 2025 Hdfc Bank Limited ₹45 Cr Open
29 Aug 2025 Others ₹70 Cr Open
28 Aug 2025 Others ₹50 Cr Open
28 Aug 2025 Yes Bank Limited ₹50 Cr Open
06 Jun 2025 The Hongkong and Shanghai Banking Corporation Limited ₹150 Cr Open

Total charge records: 10 View all charges

Employees and EPFO Compliance at Jubilant Biosys Limited

View historical data on people associated with Jubilant Biosys Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Jubilant Biosys Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Jubilant Biosys Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Jubilant Biosys Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Jubilant Biosys Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Jubilant Biosys Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Jubilant Biosys Limited

MSME Payment Delays by Jubilant Biosys Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Jubilant Biosys Limited

Subsidiaries & Group Companies of Jubilant Biosys Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Jubilant Biosys Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Jubilant Biosys Limited

MCA Filings & Documents of Jubilant Biosys Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Jubilant Biosys Limited

Charges
11 Nov 2025
A charge with Hdfc Bank Limited amounted to Rs. 45.00 Cr with Charge ID 101195242 was registered on 11 Nov 2025.
Directors
01 Sep 2025
Arul Ramakrishnan was appointed as a Whole-time director on 01 Sep 2025 & has been associated with this company since 10 months 8 days.
Charges
29 Aug 2025
A charge with Others amounted to Rs. 70.00 Cr with Charge ID 101158317 was registered on 29 Aug 2025.
Charges
28 Aug 2025
A charge with Others amounted to Rs. 50.00 Cr with Charge ID 101158469 was registered on 28 Aug 2025.
Charges
28 Aug 2025
A charge with Yes Bank Limited amounted to Rs. 50.00 Cr with Charge ID 101148870 was registered on 28 Aug 2025.
Activity
28 Aug 2025
Jubilant Biosys Limited last Annual general meeting of members was held on 28 Aug 2025 as per latest MCA records.

Recent News on Jubilant Biosys Limited

Frequently Asked Questions about Jubilant Biosys Limited

Jubilant Biosys Limited is an active public limited company in the pharma sector based in Noida, Uttar Pradesh, India. It was incorporated on 10 February 1998 (28+ years old) and is registered under CIN U24110UP1998PLC029591.

The current directors of Jubilant Biosys Limited are:

The primary industry of Jubilant Biosys Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.

Jubilant Biosys Limited can be reached at the registered office: 1A Sector 16 A, Noida, Uttar Pradesh, India – 201301, or through the website jubilantbiosys.com.

The authorised capital is ₹328 Cr, and the paid-up capital is ₹303.7 Cr.

The company has its registered office at 1A Sector 16 A, Noida, Uttar Pradesh, India – 201301.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available